Acknowledging the growing need for better control of hyperuricemia, considerable research has been dedicated to the discovery and development of innovative therapies designed to meet these clinical challenges
Semaglutide vs Tirzepatide:GLP-1 vs Dual GIP/GLP-1 Research Explained Semaglutide and Tirzepatide are among the most searched incretin-based compounds in body-composition and metabolic research
Gelinas R, Mailleux F, Dontaine J, Bultot L, Demeulder B, Ginion A, Daskalopoulos EP, Esfahani H, Dubois-Deruy E, Lauzier B, Gauthier C, Olson AK, Bouchard B, Des Rosiers C, Viollet B, Sakamoto K, Balligand JL, Vanoverschelde JL, Beauloye C, Horman S, Bertrand L (2018) AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation
These notable developments have even led to the initiation of a phase III clinical trial with exenatide (Bydureon ) as an antiparkinsonian agent, launched in the beginning of 2020 (NCT04232969)
Part One: What a Drug Patent Actually Protects The Anatomy of Pharmaceutical Patent Protection A drug patent does not protect a drug
But in recent years, many women with Lipedema have began using GLP-1s for different reasons: to help manage inflammation, pain, swelling, and mobility